[1] 刘延庆.刘延庆效方治验——资生消瘤饮[J].江苏中医药,2021,53(07):1-2.
[2] 侯超,张晓春,吴吟秋,刘延庆.《伤寒杂病论》经方抗肿瘤作用机制研究进展[J].中华中医药杂志,2021,36(01):308-310.
[3] 戴小军,于彦威,刘延庆.毒邪理论治疗肿瘤源流及辨治要法[J].中华中医药杂志,2020,35(10):5122-5127.
[4] 陆清昀,刘延庆,戴小军,侯超.刘延庆辨治乳腺癌学术特色[J].中医学报,2020,35(07):1460-1462.
[5] 戴小军,侯超,吴永健,张晓春,刘延庆.基于“脾主运化”理论论治胃癌[J].时珍国医国药,2018,29(07):1697-1699.
[6] 王海波,倪腾洋,冯俊,李丹,金凤,王维民,朱光,戴小军,陶立德,陶丽,刘延庆.南蛇藤提取物通过Cofilin1抑制胃癌BGC-823细胞转移的机制[J].中国实验方剂学杂志,2018,24(19):112-116.
[7]倪腾洋,李丹,王海波,陶丽,金凤,冯俊,钱亚云,陶立德,砂川正隆,刘延庆.华蟾素通过调控基质金属蛋白酶抑制人胃腺癌细胞MGC-803侵袭与迁移[J].中国实验方剂学志,2018,24(19):106-111.
[8] 杨婷,钱亚云,刘延庆.刘延庆治疗胃癌化疗不良反应的经验[J].江苏中医药,2016,48(10):84-85+89.
[9] 戴小军,丁健,张晓春,刘延庆.肿瘤中医康复治疗优势特色探讨[J].中国肿瘤,2014,23(06):514-517.
[10] 刘延庆,朱健泉,薛永骥,朱小平,王翊,久光正.中药复方止痛胶囊抗风湿作用机理研究[J].江苏临床医学杂志,2001(06):471-475.
[11] Ni T, Chu Z, Tao L, Zhao Y, Zhu M, Luo Y, Sunagawa M, Wang H, Liu Y. PTBP1 drives c-Myc-dependent gastric cancer progression and stemness. Br J Cancer. 2023;128(6):1005-1018.
[12] Wang H, Luo Y, Ou S, Ni T, Chu Z, Feng X, Dai X, Zhang X, Liu Y. Celastrus orbiculatus Thunb. extract inhibits EMT and metastasis of gastric cancer by regulating actin cytoskeleton remodeling. J Ethnopharmacol. 2023;301:115737.
[13] Wang H, Luo Y, Hu Y, Feng X, Feng J, Chu Z, Ou S, Dai X, Wang X, Liu Y. Triptonoterpene, a Natural Product from Celastrus orbiculatus Thunb, Has Biological Activity against the Metastasis of Gastric Cancer Cells. Molecules. 2022;27(22):8005.
[14] Chu Z, Luo Y, Ni T, Zhu M, Feng X, Liu Y, Wang H. Betulonic Acid, as One of the Active Components of the Celastrus orbiculatus Extract, Inhibits the Invasion and Metastasis of Gastric Cancer Cells by Mediating Cytoskeleton Rearrangement In Vitro. Molecules. 2022;27(3):1025.
[15] Tao L, Yin Z, Ni T, Chu Z, Hao S, Wang Z, Sunagawa M, Wang H, Liu Y. The Ethyl Acetate Extract From Celastrus orbiculatus Promotes Apoptosis of Gastric Cancer Cells Through Mitochondria Regulation by PHB. Front Pharmacol. 2021;12:635467.
[16] Jiang Z, Zhao Y, Zhao Y, Liu Y, Tao L. Pristimerin synergizes with gemcitabine through abrogating C
